An Integrated Neurophysiological Approach Toward the Early Detection of Psychiatric Disorders

Recruiting Observational Study
Schizophrenia Disorders
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 50
Sex
Any
Study type
Observational
Participants needed
75 (estimated)
Sponsor
IRCCS Centro San Giovanni di Dio Fatebenefratelli · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Schizophrenia (SCZ) is a severe neuropsychiatric disorder characterized by cognitive decline, social withdrawal, and positive symptoms such as hallucinations and delusions. Research suggests that SCZ and schizotypy exist along a continuum, with shared structural and behavioral abnormalities, the latter of which encompass the sensory and perceptual domain, often in the form of altered multisensory …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria (all participants): * Normal hearing * Normal or corrected-to-normal vision Inclusion Criteria (patients): * Clinical diagnosis of schizophrenia spectrum disorder (according to DSM-5) * IQ \> 70 Exclusion Criteria (all participants): * Anamnesis or evidence of any central ner…
Contacts

No contact information available.